47P Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01
Annals of Oncology(2021)
关键词
intrahepatic cholangiocarcinoma,fgfr2 fusions/rearrangements,derazantinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要